ROS-mediated SRMS activation confers platinum resistance in ovarian cancer.
Oncogene
; 42(20): 1672-1684, 2023 05.
Article
in En
| MEDLINE
| ID: mdl-37020040
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Platinum
Limits:
Female
/
Humans
Language:
En
Journal:
Oncogene
Journal subject:
BIOLOGIA MOLECULAR
/
NEOPLASIAS
Year:
2023
Document type:
Article
Affiliation country:
Estados Unidos